48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)